A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated
Clinical trial NCT06081530 · COMPLETED
Trial details
- NCT number
- NCT06081530
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-27
- Primary completion
- 2025-03-20
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.